Regulation of Immunity in Clear Cell Renal Carcinoma: Role of PD-1, PD-L1, and PD-L2.
Liudmila V SpirinaZahar YurmazovEvgeny UsyninIrina KondakovaEkaterine LadutkoEvgeny ChoynzonovPublished in: Current issues in molecular biology (2021)
We present a new instrument targeting pathologies with p-VHL/HIF altered function that impact the PD-L2 expression through the change in transcriptional, growth factors, and AKT/mTOR modulation.